DOCSLIB.ORG

Sg Galien 2009-8P.Qxt

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sg Galien 2009-8P.Qxt preliminary SPONSORSHIP 2009guide Prix Galien USA Committee Michael S. Brown, M.D. Nobel Laureate Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas Walter Gilbert, Ph.D. Nobel Laureate Carl M. Loeb University Professor Emeritus, Harvard University Joseph Goldstein, M.D. Nobel Laureate Worldwide, the Prix Galien is regarded Professor of Molecular Genetics and Internal Medicine, as the equivalent of the Nobel Prize UT, Southwestern Medical Center at Dallas in biopharmaceutical research. Paul Greengard, Ph.D. Nobel Laureate Vincent Astor Professor of Molecular and Cellular The award recognizes outstanding Neuroscience, Rockefeller University achievements in improving the global Eric R. Kandel, M.D. human condition through the Nobel Laureate Professor of Physiology and Cellular Biophysics, development of innovative therapies. Columbia University Richard A. Lerner, M.D. The Prix Galien was created in 1970 Lita Annenberg Hazen Professor of Immunochemistry, Chair in Chemistry, Scripps Research Institute in honor of Galen, the father of medical science and modern Paul A. Marks. M.D. pharmacology. Laboratory Head of Cell Biology, Memorial Sloan Kettering Cancer Center Bengt Samuelsson M.D. Ph.D. Nobel Laureate Professor, Karolinska Institute, Former President of Karolinska Institutet and Chairman of the Nobel Foundation Jan T.Vilcek, M.D. Professor of Microbiology, New York University School of Medicine The Prix Galien Medal Gerald Weissmann, M.D. Research Professor of Medicine (Rheumatology) Albert de Jaeger (1908 – 1992), who was awarded and Director of the Biotechnology Study Center, the Premier Grand Prix de Rome architectural prize, NYU School of Medicine designed the Prix Galien medal. He designed the Weizsman Institute medal, and medals for prominent figures such as Pope Pius XII (in 1937 at the Villa Medicis) and Pope Jean-Paul I, Elie Wiesel Presidents Dwight D. Eisenhower and John F. Kennedy, distingui- Nobel Laureate shed military leaders including Marshals Leclerc, Koenig, University Professor and Professor of Philosophy Montgomery, Marshall and Joukov; artists, literary figures and and Religion, Boston University prominent personalities such as Sacha Guitry, Marcel Proust, Honorary Member Henri de Montherlant, Paul Haris, s eve ral Nobel Prize laure a t e s , the Empress of Iran SA Fa rah Diba, Princess Grace of Monaco, and so many more… He also created many outstanding 2 monuments in France and throughout the world. Prix Galien usa 2009 - preliminary sponsorship guide Prix Galien Prix Galien in the wor l d in the USA United Kingdom "It is a great pleasure to welcome everyone "It is a pleasure to congratulate all those to the second Prix Galien USA who promote the Prix Galien and phar- Awards ceremony. Prix Galien recognizes maceutical research: they play a vital role in the fight men and women from the pharmaceutical against disease throughout the world." and biomedical industries whose contributions of John Major, Prime Minister – 1996 science have improved and saved countless lives." Michael Bloomberg, M ayor of New York City – S e p t . 2 0 0 8 Canada "The Prix Galien is a prestigious aw a r d , a m a g n i fi c e n t occasion to pay recognition to our researchers and to encourage our industry." "The Prix Galien is a welcome initiative Jean Chretien, Prime Minister – 1994 to stimulate creative research and promote excellence." France Senator Barack Obama – Sept. 2008 "We recognize the importance of the Pri x Galien in promoting drug research, and we salute the excellent wo r k of the Jury." Philippe Douste-Blazy, Minister of Health – 2004, "I applaud Prix Galien for recognizing Minister of Foreign Affairs – 2006, the pioneering spirit of America Vice-Secretary General of the innovation and research." United Nations – 2008. Senator John McCain – Sept. 2008 Switzerland "When Olympic rhymes with Galenic, there is a gold medal that can be won To Dr. Roy Vagelos on receiving the Pro for an extraordinary achievement: this is the Galien Bono Humanum Award Award, the Oscar of pharmaceutical research." "Rosalynn joins me in congratulating you Walter Suter, State Advisor, on receiving the 2007 Galien Pro Bono Director of the Public Economy – 2004 Humanum Prize at the Prix Galien Awards Ceremony. We always have been inspired by your decision, on behalf of Merck & Co., Inc., to donate Mectizan® free of charge to all who need it for as long as necessary." President Jimmy Carter – 2007 3 IMPROVING THE HUMAN CONDITION WORLDWIDE Prix Galien HALL OF FAME GlaxoSmithKline . 31 Medals 2 0 0 8 Merck-Sharp-Dohme . 31 Medals Prix Galien USA Roche . 28 Medals 2008 Winners Sanofi-Aventis. 28 Medals Best Pharmaceutical Agent: Novartis . 24 Medals Merck - Isentress / Pfizer - Selzentry Pfizer. 15 Medals Best Biotechnology Product: Alexion - Soliris / Wyeth - Infuse Janssen-Cilag . 13 Medals Special therapeutic development: Merck-Serono . 9 Medals Celgene - Revlimid Bristol-Myers Squibb. 8 Medals Pro Bono Humanum Award: Bayer Schering-Plough . 8 Medals Sheldon Segal, distinguished scientist at the Population Council Wyeth. 7 Medals Pasteur. 6 Medals Inserm / Abbott / Servier . 5 Medals Astra-Zeneca / Lilly / Schering-Plough . 4 Medals Akzo / Almirall-Prodesfarma . 3 Medals Actelion / Beaufour-Ipsen / Boehringer / Lafon / Procter & Gamble . 2 Medals Hono2r • 0Dignity • 0Respec t for7 Life Pharmaceutical Science • Basic Research Albana Pharma / Alexion / Amgen / Baxter / Biocodex / Biogen / Chiron / Ferrer / Fournier / Prix Galien USA Genzyme / Guerbet / Institut Santa Creu / Leo / Lundbeck / Menarini / Orphan / Otsuka / 2007 Winners Pierre Fabre / Service de Santé des Armées / Uriach / Best Pharmaceutical Agent: Viron Therapeutics / Celgene Corporation . 1 Medal Merck - Januvia / Pfizer - Chantix Best Biotechnology Product: Abbott - Humira / Merck - Gardasil Pro Bono Humanum Award for the River Blindness Program: Dr. Roy Vagelos 4 Prix Galien usa 2009 - preliminary sponsorship guide 2009 Prix Galien usa awa r d s Candidates may submit their entries for the following awards: • Best Pharmaceutical Agent • Best Biotechnology Product • Best Biomedical Device 2009 Prix Galien usa The committee will judge which among the candidates, independent of any category, is the Best Pharmaceutical Agent (i.e. small molecule) awards ceremon y and which is the Best Biotechnology Product approved in the USA in the past ten years. As few as one or as many as three prizes may be awarded in each of these two categories, and from time to time the Wednesday, September 30, 2009, committee may decide on awards hors prix.The prizes are awarded for pharmaceutical science that improves the human condition. 6:00 PM (tbc) American Museum of Final Candidates 2008 Actelion,Alexion Pharmaceuticals, Inc. BioMarin Natural History, New York City Pharmaceutical Inc., Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, CV Therapeutics, Elan, Eli Lilly and Master of Ceremonies: Charlie Rose (tbc) Company, GlaxoSmithKline, Merck & Co. Inc, Novartis, Nycomed, Pfizer, Roche, Sanofi Pasteur, Sanofi-Aventis, Deadline for entries: Sucampo Pharmaceuticals,Wyeth. June 30, 2009 Sponsors 2008 Gold: New Spring Capital Silver: Alexandria Real Estate, DDB Healthcare, Sepracor, Waters Corporation Bronze: Cap Gemini, Catalina Health Resource, Deloitte, New York City Economic Development Corporation, New York Biotech Association, Publicis Healthcare Group, Saint Joseph’s University. The top executives of the fol l ow i n g companies participated at the 2008 Awards Ceremony: 4Inno,Accenture,AGI Dermatics,Agile Therapeutics,AIG,Airmid, Inc, Alzheimer's Drug Discovery Foundation,Arcus Ventures,Armstrong Holdings,Aureon Laboratories, BearingPoint, Beth Israel Heart Institute, Biomedical research alliance, Bionest partners, Brand Pharm USA, Center Business Intelligence, Centerview Partners, Chicago Public Schools, CMP Medica France, Commonwealth Medical College, Conner Strong Companies, Convent of the Sacred Heart, Corbett Accel Healthcare Group, D&R Lawyers, Darby&Darby, Donahoe Purohit Miller, Dorsey & Whitney, Duke University, FMC Corporation German University Alliance, GIANT, Global Views, Golden Gate National Parks Con, Goldman Sachs, Granite Broadcasting Group, Hospital for Special Surgery, Hunter College, Hyman & Associates, Innate Pharma Inc., InterbrandHealth, Intercept Pharmaceuticals Inc., Intracellular Therapies, Inc. IntraLinks, Kaplan Thaler, Kirkland West, KVB Pertners Inc, LifeBrands Medicus, Linkergy, Louis Berger Group, Makovsky & Company, Massachusetts General Hospital, MediConsult, Medicrea USA Corp., Memorial Sloan Kettering Cancer Center, Microsoft, Mintz Levin Cohn et. al., MIT Corporation, Namar Consulting, NaniRx Therapeutics, New York Academy of Sciences, NexGenix Pharmaceuticals, NYC Law Department, NYU, Oliver Wyman, OSI Pharmaceuticals, Othera Pharmaceuticals, Paramount biosciences, PhV Corporation, Prime News Service, Queens Herald, Re-Agent USA, Robotic Systems & Technologies, Roosevelt Capital Partners, Ryder System, Saatchi & Saatchi, Scisive Consutling Somtherapeutics, Sudler & Hennessey, Surge Worldwide Healthcare Com, Susquenna Financial Group,The Goldman Sachs Group,The Scripps Research Institute,Times Newsweekly, United States Government,Vanguard,Vivaldi Biosciences,Wall Street Journal,Weber Shandwick Worldwide,WeissComm Partners,Wishbone ITP, Wolters Kluwer Health, Johnson & Johnson,Yale University. 5 Prix Galien usa 2009 - preliminary sponsorship guide Gold S p o n s o r B e n e f i t s $ 5 7 , 5 0 0
Load more

Recommended publications
  • Report Meeting with External Expert Participants To
    REPORT MEETING WITH EXTERNAL EXPERT PARTICIPANTS TO PROVIDE ADVICE ON A.I.D. RESEARCH PRIORITIES IN CONTRACEPTIVE DEVELOPMENT OCTOBER 20, 1982 Table of Contents page Current Program Description .................................................. 1 Input from A.I.D Mission and the Population Sector Council ................... 1 Issues and Discussion A. Current A.I.D. research modus operandi ............................... 2 B. A.I.D. technical staff ............................................... 2 C. Funding levels ....................................................... 2 D. Priorities ........................................................... 3 E. Product development .................................................. 3 F. Product planning ..................................................... 3 G. Safety studies ....................................................... 3 H. Developing country involvement ....................................... 4 I. Other points made .................................................... 5 Conclusion and Summary ....................................................... 5 Appendix Agenda ........................................................ ............ 6 Table 1 Biomedical Research for Contraceptive Development Fiscal Years 1978-1982 ........................................... 7 Table 2 Major Research Activities - IFRP ............................... 8 Table 3 Major Research Activities - PARFR, Population Council (ICCR), Johns Hopkins University ........... .......................... 9 Table 4 Principles
    [Show full text]
  • Annual Report 2018
    ANNUAL REPORT 2018 VOICES+ CHOICES ELEVATING VOICES. EXPANDING CHOICES. IMPROVING LIVES. POPULATION COUNCIL LETTER FROM THE PRESIDENT AND BOARD CHAIR 2018 was a year of rising voices, from growing demands for global action on violence against women to the UN’s dire warnings of climate catastrophe. In an increasingly noisy world, evidence is more important than ever. Rigorous research can reveal and elevate the voices and visibility of the world’s most marginalized people. That is why we are proud to lead the Population Council. For more than 65 years, our unique combination of workers. These are just a few of the ways our ideas biomedical and social science research has enabled and evidence are improving lives around the world. us to understand people’s lived realities and to develop and evaluate products and programs to In 2018, we were proud to see the latest evolution address their needs. And when we demonstrate in our more than 40 years of making the case for what does and doesn’t work, and design tailor- women and girls to be at the heart of global made solutions, people’s voices are transformed development. At a convening in Washington, D.C., into smart development investments. our researchers shared new findings from rigorous evaluations of girl-centered programs, including This year, the Population Council’s unparalleled that cash transfers more effectively improve contribution to contraceptive method choice was education, health, and economic outcomes when continued with the U.S. FDA’s approval of supported by programs that build girls’ social Annovera™. We are proud to have created the first assets and health knowledge.
    [Show full text]
  • Daily Iowan (Iowa City, Iowa), 1956-07-21
    • r.t • Miss ' Universe Contest LONG BEACH, CaUl. (It -Iowa's • Carol Morris, "Mi!s United States," this morning was named "){iss Universe" in the internation· aI beauty contest. The Queen was selected at 1 a.m. rrom a final .,oup 01 five contestants that in· , . ducted "Miss Germany," "Miss Italy," "Miss England." and "Miss e Sweden." Miss Morris is the only daughter '\eroing The State University of Iowa and the People of Iowa City " an Ottumwa. iowa, minister, and _ parents, the Rev. and Mrs. La· Established in 1868 - Five Ct'nls a Copy Member of Associated Press - AP L<>ased Wire and Photo Service Iowa City, Iowa, Saturday, July 21, t9 ~ 6 f verne Morris, were among the audio ence waitiDg ior the final session. They flew in today. ,. 'The runner·up In the contest MariDe Orschel of Germany, and "Miss Sweden" was third. Together with the title Miss Mor· H:ause Votes· Funds for riB won a six month motion picture cdntract at $250 a week. a COD vcr· Mble coupe, and numerous items ., clothing and jewelry. Tile Rev. Mr. Morris arter his dauehter's selection disclosed that ~ still carried in the toe of his Atom P·ower,Sp·ee.d-U-p lJloe a penny be found In the street ibortly before his daughter left leW8 to compete in the contest. Miss Morris is a 20-year-old Says British, Qrake University, Des Moines, w. Germany. 19wa, coed, who "wished upon a liar," ud became the 1956 "Miss . U.S." at L<!nlf Beach Municipal ' OKs Disputed Russians Are l¥IClltorium Thursda!'.
    [Show full text]
  • ED054957.Pdf
    DOCUMENT RESUME ED 054 957 SE 012 418 TITLE Mankind's Great Need, Population Research. INSTITUTION Population Crisis Committee, Washington, D.C. PUB DATE 71 NOTE 77p. EDRS PRICE MF-$0.65 HC-$3.29 DESCRIPTORS Biology; Contraception; *Demography; *Essays; Evaluation; Family Planning; Population Trends; *Research; Resource Materials; *Social Sciences ABSTRACT In an effort to assess what could and,should be done in the field of population research and theapplication of research findings, the Population Crisis Ccmmittee hascompiled this series of essays. Each is written by a recognizedauthority working in his own specialty in the field of population. The essays areshort, nontechnical statements of what could and should be donein particular areas and an estimate of a reasonable levelof funding required to produce useful results. Topics consideredrelate to basic research in reproduction, developments in contraception,social research, training and organization, and generalbackground of the need for and significance of population research.Thirty essays are presented. (BL) U.S. DEPARTMENT OF HEALTH, EDUCATIONA WELFARE OFFICE OF EDUCATION THIS DOCUMENT HAS BEEN REPRO- DUCED EXACTLY AS RECEIVED FROM THE PERSON OR ORGANIZATION ORIG- INATING IT POINTS OF VIEW OR OPIN- IONS STATED DO NOT NECESSARILY REPRESENT OFFICIAL OFFICE OF EDU- CATION POSITION OR POLICY , The 'Pop Ulation!risik:corniatteo:jkii;:ixicf9rporatreci' a.t.'0;'4.114-i4iyit'enel§:;:l'UndOtstaiitting'44n A:lareirer; eXiietiented':,V MANKIND'S GREAT NEED POPULATION RESEARCH I , I 1.' fiOPULATION CRISIS COMMITTEE 1730 K Street, N.W., Washington, D.C. 20006 ! , .,,,, CC TENTS Page Preface Andrew P_ O'Meara Introduction 1 Sheldon Segal GENERAL BACKGROUND Population Research More Urgent Than Ever 4 George B.
    [Show full text]
  • Free Executive Summary
    http://www.nap.edu/catalog/1793.html We ship printed books within 1 business day; personal PDFs are available immediately. Biomedical Politics Kathi E. Hanna, Editor; Committee to Study Decision Making, Division of Health Sciences Policy ISBN: 0-309-59757-9, 360 pages, 6 x 9, (1991) This PDF is available from the National Academies Press at: http://www.nap.edu/catalog/1793.html Visit the National Academies Press online, the authoritative source for all books from the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the National Research Council: • Download hundreds of free books in PDF • Read thousands of books online for free • Explore our innovative research tools – try the “Research Dashboard” now! • Sign up to be notified when new books are published • Purchase printed books and selected PDF files Thank you for downloading this PDF. If you have comments, questions or just want more information about the books published by the National Academies Press, you may contact our customer service department toll- free at 888-624-8373, visit us online, or send an email to [email protected]. This book plus thousands more are available at http://www.nap.edu. Copyright © National Academy of Sciences. All rights reserved. Unless otherwise indicated, all materials in this PDF File are copyrighted by the National Academy of Sciences. Distribution, posting, or copying is strictly prohibited without written permission of the National Academies Press. Request reprint permission for this book. Biomedical Politics http://www.nap.edu/catalog/1793.html i Biomedical Politics riginal paper book, not from the Kathi E.
    [Show full text]
  • Scientific Programme………………………………………………
    Welcome Note…………………………………………………….……...……….......................... 2 The Academy……………………………………………………………………………….............. 3 Secretariats and Registration Scientific Secretariat…………………………………………………………………………….................. 4 Organizing Secretariat………………………………………………………………………...................... 4 Congress Secretariat Desk.………………………………………………………………......................... 4 Registration Fees………………………………………………………………………………………….... 5 Scientific Information Format of the Congress …………………………………………………................................................ 7 Congress on-line………………………………………………………… ……………………………........ 7 Computer Projection…………………………………………………… ………………………………...... 8 Preview Room.…………………………………………………………….……………………………....... 8 Oral Presentation…………………………………………………………………………………………..... 8 Poster Session……………………………………………………………………………………………..... 8 Poster Awards……………………………………………………………………………………………...... 8 General Information Congress venue…………………………………………………………………………………………...... 9 Conference halls…………………………………………………………................................................. 9 List of Contents Secretariat………………………………………………………………………………………………........ 9 Dedicated rooms…………………………………………………………................................................. 9 Congress on-line ………………………………………………………………………………………........ 9 Exhibition area…………………………………………………………………………………………......... 9 Lunch points……………………………………………………………………………………………......... 9 Coffee……………………………………………………………………................................................... 9 Official language………………………………………………………………………………………….....
    [Show full text]
  • Norplant: the New Scarlet Letter?
    Journal of Contemporary Health Law & Policy (1985-2015) Volume 8 Issue 1 Article 15 1992 Norplant: The New Scarlet Letter? Michael T. Flannery Follow this and additional works at: https://scholarship.law.edu/jchlp Recommended Citation Michael T. Flannery, Norplant: The New Scarlet Letter?, 8 J. Contemp. Health L. & Pol'y 201 (1992). Available at: https://scholarship.law.edu/jchlp/vol8/iss1/15 This Essay is brought to you for free and open access by CUA Law Scholarship Repository. It has been accepted for inclusion in Journal of Contemporary Health Law & Policy (1985-2015) by an authorized editor of CUA Law Scholarship Repository. For more information, please contact [email protected]. NORPLANT: THE NEW SCARLET LETTER? Michael T. Flannery* [W]hat is it but to laugh in the faces of our godly magistrates, and make a pride out of what they, worthy gentlemen, meant for a punishment?1 Hester Prynne lived in the eighteenth century in an early New England, Puritan colony and is a character of Nathaniel Hawthorne's classic Ameri- can novel, The Scarlet Letter.2 Darlene Johnson was born in 1964 and pres- ently lives in California.' Except for the decision of Judge Howard Broadman,4 these two women would have nothing in common. However, when Judge Broadman ordered Darlene Johnson to undergo the implanta- tion of Norplant5 to effectuate sterilization,6 the two women then shared a common bond: for the crime they each committed, both were sentenced, in effect, to shame. Hester's crime was adultery; Darlene's crime was child abuse." What is ironic is that in an age when criminals were chained to the * Assistant City Solicitor, Law Department, City of Philadelphia; B.A., The University of Delaware; J.D., The Catholic University of America, The Columbus School of Law.
    [Show full text]
  • Annual Report 2018
    ANNUAL REPORT 2018 VOICES+ CHOICES ELEVATING VOICES. EXPANDING CHOICES. IMPROVING LIVES. POPULATION COUNCIL LETTER FROM THE PRESIDENT AND BOARD CHAIR 2018 was a year of rising voices, from growing demands for global action on violence against women to the UN’s dire warnings of climate catastrophe. In an increasingly noisy world, evidence is more important than ever. Rigorous research can reveal and elevate the voices and visibility of the world’s most marginalized people. That is why we are proud to lead the Population Council. For more than 65 years, our unique combination of workers. These are just a few of the ways our ideas biomedical and social science research has enabled and evidence are improving lives around the world. us to understand people’s lived realities and to develop and evaluate products and programs to In 2018, we were proud to see the latest evolution address their needs. And when we demonstrate in our more than 40 years of making the case for what does and doesn’t work, and design tailor- women and girls to be at the heart of global made solutions, people’s voices are transformed development. At a convening in Washington, D.C., into smart development investments. our researchers shared new findings from rigorous evaluations of girl-centered programs, including This year, the Population Council’s unparalleled that cash transfers more effectively improve contribution to contraceptive method choice was education, health, and economic outcomes when continued with the U.S. FDA’s approval of supported by programs that build girls’ social Annovera™. We are proud to have created the first assets and health knowledge.
    [Show full text]
  • Pro Bonofinal.LD
    CONTACT: Brandi Horton (202) 248-5447 FOR IMMEDIATE RELEASE Population Council, Sheldon Segal to Be Celebrated by Prix Galien USA Pro Bono Humanum Award recognizes exemplary partnership benefiting reproductive health of more than 8 million women NEW YORK (July 17, 2008) — The Population Council and Sheldon Segal, distinguished scientist at the organization, will receive the Prix Galien USA 2008 Pro Bono Humanum Award (http://www.prix-galien- usa.com) for spearheading a preeminent coalition between academic, private, philanthropic and industrial organizations that made possible the development and distribution of implantable hormone delivery systems, such as Norplant®, that are used by more than 8 million women worldwide. The award also will recognize other coalition members the Rockefeller Brothers Fund, the late Judah Folkman of Harvard University, Dow-Corning and Wyeth. The award will be presented September 24, 2008, at the American Museum of Natural History in New York City. The Pro Bono Humanum Award will honor the Population Council and Segal for five decades of a science-based global effort in support of reproductive health and family planning, especially in underdeveloped or underserved populations. This initiative was critical in establishing a coalition to create Norplant® (levonorgestrel implants) and related hormone delivery systems, which came as the result of basic biomedical discovery and translational research and was put into practice thanks to the waiving of proprietary patent rights for the Population Council. “The significance of Norplant® is more than convenient birth control,” said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.
    [Show full text]
  • Contraceptive Update
    CONTRACEPTIVE UPDATE DR. SHELDON SEGAL* I. INTRODUCTION Worldwide, there has been a dramatic increase in contraceptive use over the past thirty-five years. The number of couples using systems of fertility control (the prevalence rate) has increased more than tenfold. In developing countries, the number of contraceptive users increased from under 30 million before 1960, to almost 400 million in 1996. The percent of couples in the reproductive age group using contraception has increased from 8 percent to over 50 percent and is continuing to rise in most of the developing world.' Consequently, fertility has been steadily declining. In developing countries, the number of children a woman will have in her lifetime has decreased from approximately six in the 1960s, to less than four today2 Most industrialized countries are at, or even below, replacement levels of fertility. National surveys have provided detailed information on the methods that people choose to prevent pregnancy. Around the world, contraception is practiced chiefly by women. Surgical sterilization, primarily tubal liga- tion, ranks first among methods chosen by American couples. 3 Oral con- traception is the most widely used reversible method.4 In other countries, the pattern is different. In Sweden and France, the intrauterine device (IUD)is the preferred reversible method.' In Japan, modem hormonal methods for women are not openly available, and the predominant method of birth control is the condom.6 Given the high failure rate of condom use, this means that many women ultimately must resort to having an abortion. Over one quarter of pregnancies in Japan are voluntarily terminated.7 * Distinguished Scientist at the Population Council, New York, NY.
    [Show full text]
  • Support (Earth) Hood
    THE NUOAZINI Or SUBSTANCE VOL. XIX SUMMER 1991 $2.95 FOR PROGRESSIVE WOMEN SUPPORT OF (EARTH) HOOD A Conversation with Earth First! Activist Judi Bari • The Uncommon Women of Greenham • Critiques W'a of New Contraceptives • • — m WmBK -It I •in I =00 =^ I =b I -•* --* New Books for Women on Women's Concerns! JEWISH WOMEN IN WOMEN AND DIVORCE/ THERAPY MEN AND DIVORCE Seen But Not Heard Gender Differences in Edited by Rachel Josefowitz Siegel, MSW, Separation, Divorce, and Ellen Cole, PhD and Remarriage "The [chapters] in this volume are marked by WOMAN-DEFINED compassion, intimacy, and a feminist willing- Edited by Sandra S. Volgy, PhD MOTHERHOOD ness to explore the terrain where the personal, "Solid research based data for gender issues in the mythical, the historical, the pathological, separation, divorce, and remarriage.... It is a Edited by Jane Price Knowles, MD, and the therapeutic all intersect."—Susan very valuable resource for the clinician who takes and Ellen Cole, PhD Weidman Schneider, Editor, Lilith Magazine; seriously the need for substantive date analysis "An intellectually and emotionally riveting Author of Jewish and Female and results. It is also a book which could be very book. The contributions from these talented au- Here is the first volume ever to focus on the helpful to an individual or couple who want to thors expose the unidimensional myths of issues of Jewish women in the context of coun- have more cognitive data and a deeper under- motherhood and delineate the multifaceted na- seling and psychotherapy. The authors convey standing of both men and women and divorce is- ture of being a mother...
    [Show full text]
  • The Politics of Norplant: Feminism, Civil Rights, and Social Policy in the 1990S
    ROCKEFELLER ARCHIVE CENTER RESEARCH REPO RTS The Politics of Norplant: Feminism, Civil Rights, and Social Policy in the 1990s by Justina Licata University of North Carolina at Greensboro © 2017 by Justina Licata In 1990, feminists and doctors hailed the long-term birth control device, Norplant, as the greatest advancement in birth control technology since the 1960s. By 2002, in response to an avalanche of feminist criticism and over 200 class action lawsuits, Norplant’s distributor removed the contraceptive device from the U.S. market. My dissertation, the first historical study of the drug, links the politics of Norplant to the expansion of feminism, the politicization of class action lawsuits, and the rise of neoliberalism in the 1990s. My research suggests that Norplant’s link to reproductive injustices began as early as the drug’s development. In 1966, the Population Council, an organization dedicated to balancing birth and death rates to stabilize increases in the population, began the research and development of the contraceptive device. The 1981 Norplant test trial in Bangladesh revealed how the misuse of Norplant could violate women’s rights. The scientists and doctors who carried out the trials did not properly inform many of the women participants about Norplant’s potential side effects or the procedures of the medical trial. Additionally, when women who experienced negative side effects attempted to get Norplant surgically removed, some doctors refused to take it out. While many women eagerly anticipated Norplant’s arrival in the U.S., the use of the drug to restrict minority and poor women’s reproductive rights swiftly sullied Norplant’s reputation.
    [Show full text]